A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.|Department of Pediatrics, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
Y
Y
Gocho
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.
N
N
Kiyokawa
Division of Genetics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
H
H
Ichikawa
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.
K
K
Nakabayashi
Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan.
T
T
Osumi
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.|Department of Pediatrics and Adolescent Medicine, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.
T
T
Ishibashi
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.
H
H
Ueno
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.|Department of Pediatrics, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan.
K
K
Terada
Department of Molecular Medical Research, Tokyo Metropolitan Institute of Medical Science Setagaya-ku, Tokyo, Japan.
K
K
Oboki
Division of Genetics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
H
H
Sakamoto
Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan.
Y
Y
Shioda
Department of Pediatrics, Japanese Red Cross Musashino Hospital, Musashino, Tokyo, Japan.
M
M
Imai
Department of Pediatrics, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan.
Y
Y
Noguchi
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Y
Y
Arakawa
Department of Pediatrics, Toho University Omori Medical Center, Ota-ku, Tokyo, Japan.
Y
Y
Kojima
Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.
D
D
Toyama
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.
K
K
Hata
Division of Genetics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
T
T
Yoshida
Department of Allergy and Immunology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.
K
K
Matsumoto
Department of Pediatrics, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
M
M
Kato
Department of Pediatrics, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
T
T
Fukushima
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
K
K
Koh
Department of Pediatrics, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.
A
A
Manabe
Department of Pediatrics, Toho University Omori Medical Center, Ota-ku, Tokyo, Japan.
A
A
Ohara
D000293:Adolescent; D002648:Child; D050881:E1A-Associated p300 Protein / Q000235:genetics*; D005260:Female; D050939:Gene Fusion; D006801:Humans; D008297:Male; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics*; D015534:Trans-Activators / Q000235:genetics*
D015534:Trans-Activators; C498621:ZNF384 protein, human; D050881:E1A-Associated p300 Protein; C494360:EP300 protein, human